Genetics Generation Advancement Corp. (TPEX:4160)

Market Cap	1.15B -33.4%
Revenue (ttm)	603.11M -8.9%
Net Income	21.37M -60.9%
EPS	0.80 -60.8%
Shares Out	26.69M
PE Ratio	53.88
Forward PE	n/a
Dividend	1.85 (4.24%)
Ex-Dividend Date	Oct 3, 2025

Volume	39,326
Average Volume	42,232
Open	43.50
Previous Close	43.10
Day's Range	43.10 - 43.65
52-Week Range	43.00 - 60.50
Beta	0.49
RSI	34.13
Earnings Date	May 14, 2026

About TPEX:4160

Genetics Generation Advancement Corp. provides genetic testing, molecular and science diagnostics, biotechnology, precision health, and digital innovation services in Taiwan. The company offers testing services, including pre-implantation, prenatal, newborn medical examination, health management, reproductive medicine testing, obstetrics and gynecology testing, and neonatology and pediatrics testing, as well as gastroenterology, hepatology, oncology, and medical research services. It also provides bioinformatic, materials sciences, research and...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2008
• Employees: 104
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4160

Financial Performance

In 2025, TPEX:4160's revenue was 603.11 million, a decrease of -8.88% compared to the previous year's 661.86 million. Earnings were 21.37 million, a decrease of -60.93%.